M. Sadeçolak, “Increased Risk of Hepatitis B Virus Reactivation in Patients with Resolved Hepatitis B Virus Infection Receiving Combination Immunosuppressive Therapy: The Role of Anti-HBs Status”, Turkish Journal of Gastroenterology, vol. 37, no. 7, pp. 793–801, Jun. 2026.